Literature DB >> 16048987

Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.

GholamAli Khoschsorur1, Franz Fruehwirth, Sieglinde Zelzer.   

Abstract

A simple, specific method is presented for simultaneous determination of voriconazole and itraconazole and its metabolite, hydroxyitraconazole, in human serum using one-step liquid-liquid extraction and high-performance liquid chromatography. Linearity tests ranged from 0.1 to 8.0 microg/ml; the minimum detectable concentration was 0.03 microg/ml.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16048987      PMCID： PMC1196257          DOI： 10.1128/AAC.49.8.3569-3571.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  High-dose itraconazole in the treatment of severe mycoses.

Authors:  P K Sharkey; M G Rinaldi; J F Dunn; T C Hardin; R J Fetchick; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine.

Authors:  J K Crane; H T Shih
Journal:  Am J Med       Date:  1993-10       Impact factor: 4.965

3.  Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.

Authors:  J R Perfect; D V Savani; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

Review 4.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 5.  The clinical pharmacokinetics of itraconazole: an overview.

Authors:  J Heykants; A Van Peer; V Van de Velde; P Van Rooy; W Meuldermans; K Lavrijsen; R Woestenborghs; J Van Cutsem; G Cauwenbergh
Journal:  Mycoses       Date:  1989       Impact factor: 4.377

6.  Treatment of invasive aspergillosis with itraconazole.

Authors:  D W Denning; R M Tucker; L H Hanson; D A Stevens
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

7.  Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high-performance liquid chromatography.

Authors:  V Srivatsan; A K Dasgupta; Prashant Kale; Rama Raju Datla; Devangi Soni; Mahendra Patel; Rakesh Patel; Chandrakant Mavadhiya
Journal:  J Chromatogr A       Date:  2004-03-26       Impact factor: 4.759

8.  Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations.

Authors:  J S Hostetler; J Heykants; K V Clemons; R Woestenborghs; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

9.  Potential use of a simplified method for determination of itraconazole levels in plasma and esophageal tissue by using high-performance liquid chromatography.

Authors:  R O Darouiche; A Setoodeh; E J Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Liquid chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies.

Authors:  Jia Woei Wong; Ur-Rahman Nisar; Kah Hay Yuen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-12-25       Impact factor: 3.205
View more
  13 in total

1.  Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.

Authors:  Lorena Baietto; Antonio D'Avolio; Giusi Ventimiglia; Francesco Giuseppe De Rosa; Marco Siccardi; Marco Simiele; Mauro Sciandra; Giovanni Di Perri
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  Human tissue distribution of voriconazole.

Authors:  Stefan Weiler; David Fiegl; Róisín MacFarland; Eva Stienecke; Rosa Bellmann-Weiler; Stefan Dunzendorfer; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis.

Authors:  Stefan Weiler; Heinz Zoller; Ivo Graziadei; Wolfgang Vogel; Rosa Bellmann-Weiler; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

4.  Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography.

Authors:  Kathrin Kahle; Peter Langmann; Diana Schirmer; Ulrike Lenker; Daniela Keller; Annegret Helle; Hartwig Klinker; Werner J Heinz
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

5.  Concentrations of voriconazole in healthy and inflamed lung in rats.

Authors:  Christian Joukhadar; Christiane Thallinger; Wolfgang Pöppl; Florian Kovar; Karl H Konz; Samir M Joukhadar; Friederike Traunmüller
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

6.  Role of therapeutic drug monitoring of voriconazole in the treatment of invasive fungal infections.

Authors:  I Fan Kuo; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2009-11

7.  Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.

Authors:  Xiaoyan Liu; Haibin Su; Jingjing Tong; Jing Chen; Haozhen Yang; Long Xiao; Jinhua Hu; Lina Zhang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

8.  Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients.

Authors:  Hamidreza Taghvaye Masoumi; Molouk Hadjibabaie; Mohammad Vaezi; Ardeshir Ghavamzadeh
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

9.  Stability-indicating high-performance thin-layer chromatographic method for analysis of itraconazole in bulk drug and in pharmaceutical dosage form.

Authors:  Shalin K Parikh; Jayant B Dave; Chhagan N Patel; Badmanaban Ramalingan
Journal:  Pharm Methods       Date:  2011-04

10.  Fatal invasive aspergillosis caused by Aspergillus niger after bilateral lung transplantation.

Authors:  Enora Atchade; Sylvain Jean-Baptiste; Sandrine Houzé; Claire Chabut; Laurent Massias; Yves Castier; Olivier Brugière; Hervé Mal; Philippe Montravers
Journal:  Med Mycol Case Rep       Date:  2017-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.